Company · CIK 0001017491
SEELOS THERAPEUTICS, INC.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
NV
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/ASEELOS THERAPEUTICS, INC.0000929638-24-004157 · 61.0 KBSEC(opens sec.gov)
- 8-KCurrent report0001099910-24-000383 · 208.5 KBSEC(opens sec.gov)
- SC 13G/ASEELOS THERAPEUTICS, INC.0000929638-24-003937 · 87.9 KBSEC(opens sec.gov)
- SC 13GSEELOS THERAPEUTICS, INC.0000929638-24-003740 · 61.0 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-24-111155 · 227.7 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-24-108396 · 214.7 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-24-106406 · 205.0 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-24-103143 · 228.3 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-24-102625 · 1.0 MBSEC(opens sec.gov)
- S-1IPO registration0001104659-24-102540 · 559.2 KBSEC(opens sec.gov)
Insiders
- ANDERSON KENNETHOfficer, (s) to Issuer
- ARMISTICE CAPITAL, LLC10% Owner
- Berholtz RandyE.V.P., General Counsel & Sec.
- BERMAN RICHARD JDirector
- Boyd Steven10% Owner
- Cox Edward M.VP of Business Development
- Crea RobertoDirector
- DALESANDRO MARGARETDirector
- Damaj BassamDirector, President and CEO
- DENNER ALEXANDER J10% Owner
Tickers
No tickers on record.
Addresses
business
300 PARK AVENUE 2ND FLOOR
NEW YORK, NY, 10022
mailing
300 PARK AVENUE 2ND FLOOR
NEW YORK, NY, 10022
Former names
- APRICUS BIOSCIENCES, INC.2019-01-24
- NEXMED INC2010-09-13
Same industry